SHL Medical to speak and exhibit at 2023 PDA Universe conference in Gothenburg
SHL Medical will exhibit at Booth #85 of the 2023 Parenteral Drug Association (PDA) annual Universe of Pre-filled Syringes and Injection Devices Conference on October 17-18 in Gothenburg, Sweden.
This year, SHL Medical representatives are poised to take center stage at the conference and deliver novel insights on various topics from sustainability, autoinjector manufacturing, to digital health. In addition, SHL Medical will unveil the latest solution from our comprehensive product offering, the Molly® Connected Cap autoinjector. Driven by our success with Molly autoinjectors, Molly Connected Cap was developed as part of a therapeutics platform that can provide patients with a standalone solution to manage their self-injection activities.
We are also proud to announce that SHL Medical’s Global Head of Portfolio, Strategy, and Customer Solutions, Bart Burgess, has been invited to speak at the 2023 PDA The Future of Drug Delivery Workshop. This opportunity serves as a testament to SHL Medical’s active involvement in driving forward the frontiers of the drug delivery industry and demonstrates our continuous contribution to the development of innovative autoinjector technology.
We invite all event attendees to join our speakers during the presentation sessions and interact with them at our booth. Our team will be delighted to engage with you, providing in-depth demonstrations and expert insights into SHL Medical’s comprehensive solutions, including the market-proven Molly autoinjector and the Needle Isolation Technology (NIT®)-integrated Maggie® autoinjectors. Don’t miss this invaluable opportunity to experience firsthand SHL Medical’s global expansion and end-to-end manufacturing capabilities.
We look forward to welcoming you.
When: October 17-18, 2023
Where: Gothenburg, Sweden | Booth #85
Meet our speakers!
Podium presentations
|
Title |
Speakers |
Time |
|
2023 PDA The Future of Drug Delivery Workshop – Transitioning from Transactional Mindset to Collaborative Approach: A Vendor Perspective on Product Development |
Bart Burgess Global Head of Portfolio, Strategy, and Customer Solutions, SHL Medical |
October 16 10:30 AM CEST |
|
A Parametric Model Developed from Activity-Based Footprinting to Simplify the Complexity of Lifecycle Assessment Towards Sustainable Autoinjector Devices |
Veluska Bruce, PhD ESG Project Manager, SHL Medical |
October 18 11:05 AM CEST | Session 3A |
Poster presentations
|
Title |
Authors |
|
Pre-filled Syringe and Device Testing for the Development of Autoinjector Combination Products |
Lucy Lee, MSc Associate Director, SHL Medical |
|
Yannick Daehler, MSc Product Engineer, SCHOTT Pharma |
|
|
Leveraging Data Analytics to Ensure Consistent Autoinjector Performance for Production Ramp-up |
Hung Kai Ting, PhD Senior Engineer, SHL Medical |
|
Kurt Chang, MSc Principal Engineer, SHL Medical |
|
|
Embedding Connectivity in the Lifecycle of an Autoinjector – An Innovation Partnership Exploratory Case Study |
Chelsea Williams, MPH Digital Health Manager, SHL Medical |
|
Rethinking Human Factors in Obesity: Development of Simulation and Physical Test Models of Human Soft Tissue to Study Autoinjector Activation Performance |
Eric Linvill, PhD Senior CAE Engineer, SHL Medical |
|
Chung Tsai, MSc Verification Engineer, SHL Medical |
|
|
Exemption for Dose Accuracy in Test Method Validation of Autoinjector Platforms |
Joseph Chou Senior Engineer, SHL Medical |
Tech Talk
|
Title |
Speaker |
Time |
|
Connected Autoinjectors: Usability and Joint Innovation |
Chelsea Williams, MPH Digital Health Manager, SHL Medical |
October 17 1:30 PM CEST |
